Latest News Archive
Please select Category, Year, and then Month to display items
12 December 2024
|
Story Lacea Loader
|
Photo Supplied
Dr Cias Tsotetsi, newly appointed Campus Vice-Principal: Academic and Research on the UFS Qwaqwa Campus.
The University of the Free State (UFS) is pleased to announce the appointment of Dr Cias Tsotetsi as the Campus Vice-Principal: Academic and Research on the UFS Qwaqwa Campus as from 1 January 2025.
He is currently Senior Lecturer and Assistant Dean in the Faculty of Education on the UFS Qwaqwa Campus. He holds the following qualifications: BEd(Hons), Postgraduate Diploma in Education, Magister Educationis with specialisation in Policy Studies and Governance in Education, and PhD with specialisation in Philosophy and Policy Studies in Education – all from the UFS.
Dr Tsotetsi operated in the school environment for about 24 years before joining this university in 2010. Since then, he has taught several modules in the Faculty of Education and published several co-authored research articles as well as conference papers on community engagement, teacher development, and participatory action research methodologies, among others. He is also well versed in supervising postgraduate students.
He has received awards from both the university’s Scholarship of Teaching and Learning and the Research committees for his research and academic scholastic performance. He is a member of various committees, such as the Faculty of Education Academic Advisory Board and the Committee for Title Registration and has been participating in partnerships and in NRF-funded projects with peers from universities such as the University of KwaZulu-Natal, the University of Zululand, the Durban University of Technology, and the University of Venda.
“Dr Tsotetsi has a clear understanding of the current systems and operations on the Qwaqwa Campus and is positioned to drive its development. His experience and initiatives involving staff and postgraduate students are exceptional and inspiring. We look forward to Dr Tsotetsi’s valuable contribution to the UFS Qwaqwa Campus and the institution in his new position,” says Prof Prince Ngobeni, Campus Principal of the Qwaqwa Campus.
“I feel honoured to serve the university – and the Qwaqwa Campus in particular – and look forward to working with the campus and its management to develop the research portfolio,” says Dr Tsotetsi.
DNA sequencer launched at the UFS
2013-11-25
 |
| Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them. |
The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.
The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.
The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.
The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.
The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.
“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.
Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”